TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Diameter of the radial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuromotor behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetic retinopathy progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GI toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: overall recurrence risk
Endpoint domain: Mortality/survival
Primary endpoint: Heart Failure (HF) risk
Endpoint domain: Mortality/survival
Primary endpoint: Impact of fibromyalgia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FSSG scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: clinical attachment loss (CAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Professional guidance and support
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recovery acceleration through strength training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough score during extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Throat pain score after extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle strength of the lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: activity of the lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: daily living ability of patients
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cases of confirmed Marburg virus disease
Endpoint domain: Mortality/survival
Primary endpoint: ARR (Atypical Root Resorption) prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of cultured S aureus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: session completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean session ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to positivity (TTP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: objectively measured vegetable intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMNP voucher redemption rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ∆-lean body mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infarct expansion ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NAA peaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Documentation completeness
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of grade 1 oral mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of grade 2 oral mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Safe sex behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate antimicrobial effect on S marcescens
Endpoint domain: Adverse events/effects
Primary endpoint: hospitalization cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Complete remission achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of blood pressure on coronary artery disease risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Trunk fat percentage and other adiposity measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: decision-making certainty
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: elevation of specific proteins in SA compared to MMA and HCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequate recollection of broad consent for randomization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean reduction in stone size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hepatic fat reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Physical health (PCS-12 score)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mental health (MCS-12 score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: peak overall drug effect strength
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: desire to take the drug condition again
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Auditory Comprehension Test (ACT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nutritional risk (Standardized Phase Angle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in pain from baseline at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transepidermal water loss (TEWL) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin pH reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: GAS carriage in the nasopharynx
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of azithromycin-resistant GAS
Endpoint domain: Adverse events/effects
Primary endpoint: Completeness of discharge summaries (DS)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Positive rate of HEV-IgG antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean concentration (GMC) of HEV-IgG antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: corneal incision enlargement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction in total peripheral resistance (TPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PBF (Pulsatile Blood Flow)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intravascular uptake incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predicting sarcopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimating appendicular skeletal muscle mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Organizational readiness for change scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gender-equitable attitudes on the overall GEM scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Life-years (LYs)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of P. vivax infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cumulative incidence of P. vivax infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants with at least one recurrent infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in cognitive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction of BP-related CVD burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospitalizations for AMI
Endpoint domain: Mortality/survival
Primary endpoint: Post-discharge deaths from AMI
Endpoint domain: Mortality/survival
Primary endpoint: 12-month MCS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: T25FW (Timed 25-Foot Walk)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substance use management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uterine tachysystole
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: modified Rankin Scale (mRS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of one-time block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of hip arthroscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drain output volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study enrollment likelihood
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: duration of safe apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative increase of CK
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean absolute error in food portion estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative error scores in food portion estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall improvement in estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Undetectable minimal residual disease (MRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of hypothermia requiring escalation of care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of exclusive breastfeeding at discharge
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SALT score of 20 points or less post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Response to scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MFPDI score change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Plasma retinol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balanced accuracy in classifying advanced AMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balanced accuracy in classifying referable AMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balanced accuracy on the 4-step AMD severity scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dispositional coping style
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subsequent HCV test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with learning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Operative errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Confidence in abilities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weight of Advice (WOA) difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implant insertion torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periprocedural pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to tracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: costs per person-year
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: area under the curve (AUCtau)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical response
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: parasomnia frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parasomnia severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new morbidity
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of women with a Hb drop of 2 g/dL or greater
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 3-month postintracerebral hemorrhage modified Rankin Scale (0-3 vs 4-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perception of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: tactile perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: IgG antibody response against PD03
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IUD symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % change bone mineral density (BMD) at the femoral neck at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: % change total body BMD at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean radius re-angulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAL improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in UMSARS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in blood neurofilament light chain (NfL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in whole brain volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean log10 CFU reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Volume of blood components transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Requirement of fresh frozen plasma (FFP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cost-effectiveness of ROTEM-guided transfusion strategy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: comprehension of urinary incontinence education
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to produce colostrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of 24-h vaginal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Function Questionnaire‐25 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PRSA-deceleration capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PRSA-acceleration capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: objectively measured swallowing function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-perceived swallowing function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall score of the Manchester Scar Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: immediate recall of a visuomotor task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: post-sleep recall of a visuomotor task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: burning sensation improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of take
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Epithelialization time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: POSAS scar assessment scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Compliance with therapeutic objectives
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: need for endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Decrease in ALT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver stiffness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical benefit
Endpoint domain: Life impact
Primary endpoint: Efficient duration of MDA delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of patient‐controlled epidural analgesia (PCEA) compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of IL‐6 and CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 12-month Progression-Free Survival rate
Endpoint domain: Mortality/survival
Primary endpoint: muscle fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: anterior deltoid activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: resourcefulness
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: sociability
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Abdominal circumference after feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric residual volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State of alertness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hamstring strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: HAMD-17 T scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain subscale T scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to application
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: change in p
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MSISQ-19 score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MFI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety score alteration
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Life in individuals with severe MSI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: gaze stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Alzheimer's disease assessment scale‐cognitive score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dynamic pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reporting quality of trial protocols
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: No grade II or higher adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery of functional capacity of T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of depressive symptoms related to positive drug screen for Mandrax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total grade based on POSAS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: depression scores on the Patient Health Questionnaire-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Seizure duration during sitting HV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Seizure duration during supine HV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of absence seizures during sitting HV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: peak vertical ground reaction force during jump landing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: force during dominant leg cutting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hip-flexion torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Control of blood glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic accuracy for malignant ovarian tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Heart failure hospitalization
Endpoint domain: Physiological/clinical
Primary endpoint: Inter-observer reliability of SYNTAX scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intra-observer reliability of risk classification scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: TFBUT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of headache medication overuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes